References

1. 1.
   WANG H，LIU D，ZHENG B，et al.Emerging role of ferroptosis in diabetic kidney disease：Molecular mechanisms and therapeutic opportunities［J］.Int J Biol Sci，2023，19（9）：2678-2694.
2. 2.
   SAEEDI P，PETERSOHN I，SALPEA P，et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045： Results from the International Diabetes Federation Diabetes Atlas， 9（th） edition［J］.Diabetes Res Clin Pract，2019，157：107843.
3. 3.
   TANG A，ZHANG Y，WU L，et al. Klotho's impact on diabetic nephropathy and its emerging connection to diabetic retinopathy［J］.Front Endocrinol（Lausanne），2023，14：1180169.
4. 4.
   INADA A，INADA O，YASUNAMI Y，et al. Amelioration of murine diabetic nephropathy with a SGLT2 inhibitor is associated with suppressing abnormal expression of hypoxia-inducible factors［J］.Am J Pathol，2022，192（7）：1028-1052.
5. 5.
   NIU G，ZHOU M，WANG F，et al. Marein ameliorates Ang Ⅱ/hypoxia-induced abnormal glucolipid metabolism by modulating the HIF-1α/PPARα/γ pathway in H9c2 cells［J］.Drug Dev Res，2021，82（4）：523-532.
6. 6.
   WANG S，QIN S，CAI B，et al.Promising therapeutic mechanism for Chinese herbal medicine in ameliorating renal fibrosis in diabetic nephropathy［J］.Front Endocrinol（Lausanne），2023，14：932649.
7. 7.
   RUAN Y，LING J，YE F，et al. Paeoniflorin alleviates CFA-induced inflammatory pain by inhibiting TRPV1 and succinate/SUCNR1-HIF-1α/NLPR3 pathway［J］.Int Immunopharmacol，2021，101（Pt B）：108364.
8. 8.
   CHANG J，ZHENG J，GAO X，et al.Tangshen Weining formula prevents diabetic nephropathy by protecting podocytes through the SIRT1/HIF-1α pathway［J］.Front Endocrinol（Lausanne），2022，13：888611.
9. 9.
   SEMENZA G L，WANG G L.A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation［J］.Mol Cell Biol，1992，12（12）：5447-5454.
10. 10.
    LIAO Q，DENG H，WANG Z，et al.Deletion of prolyl hydroxylase domain-containing enzyme 3（PHD3） in zebrafish facilitates hypoxia tolerance［J］.J Biol Chem，2023，299（12）：105420.
11. 11.
    ZHANG Y，YANG Y，HU X，et al.RAS protein activator-like 2 （RASAL2） initiates peritubular capillary rarefaction in hypoxic renal interstitial fibrosis［J］.Transl Res，2024，269：14-30.
12. 12.
    WANG D，WANG F，HUANG Y，et al.TSLP/TSLPR promotes renal fibrosis by activating STAT3 in renal fibroblasts［J］.Int Immunopharmacol，2023，121：110430.
13. 13.
    TANG M，LI Q Y，LI S B，et al.Effects of L-mimosine on renal hypoxia and HIF/PHD axis in diabetic rats［J］.J Zunyi Med Univ，2019，42（5）：527-533.
14. 14.
    GUAN Z，JIN X，GUAN Z，et al.The gut microbiota metabolite capsiate regulate SLC2A1 expression by targeting HIF-1α to inhibit knee osteoarthritis-induced ferroptosis［J］.Aging Cell，2023，22（6）：e13807.
15. 15.
    IACOBINI C，VITALE M，HAXHI J，et al.Mutual regulation between redox and hypoxia-inducible factors in cardiovascular and renal complications of diabetes［J］.Antioxidants（Basel），2022，11（11）：2183.
16. 16.
    JATHO A，ZIESENISS A，BRECHTEL-CURTH K，et al.The HIFα-stabilizing drug roxadustat increases the number of renal epo-producing Sca-1⁺ cells［J］.Cells，2022，11（4）：753.
17. 17.
    WU M，CHEN W，MIAO M，et al.Anti-anemia drug FG4592 retards the AKI-to-CKD transition by improving vascular regeneration and antioxidative capability［J］.Clin Sci（Lond），2021，135（14）：1707-1726.
18. 18.
    ZHENG X，LIU D.Adiponectin alleviates the symptoms of ischemic renal disease by inhibiting renal cell apoptosis［J］.Life Sci，2021，265：118825.
19. 19.
    SAMAAN E，RAMADAN N M，ABDULAZIZ H，et al.DPP-4i versus SGLT2i as modulators of PHD3/HIF-2α pathway in the diabetic kidney［J］.Biomed Pharmacother，2023，167：115629.
20. 20.
    PACKER M.Mechanisms leading to differential hypoxia-inducible factor signaling in the diabetic kidney modulation by SGLT2 inhibitors and hypoxia mimetics［J］.Am J Kidney Dis，2021，77（2）：280-286.
21. 21.
    HE J Y，HONG Q，CHEN B X，et al Ginsenoside Rb1 alleviates diabetic kidney podocyte injury by inhibiting aldose reductase activity［J］.Acta Pharmacol Sin，2022，43（2）：342-353.
22. 22.
    SUN H，LI X，CHEN X，et al. Drp1 activates ROS/HIF-1α/EZH2 and triggers mitochondrial fragmentation to deteriorate hypercalcemia-associated neuronal injury in mouse model of chronic kidney disease［J］.J Neuroinflammation，2022，19（1）：213.
23. 23.
    LIANG S，NAYAK B K，VOGEL K S，et al.TP63 Is significantly upregulated in diabetic kidney［J］.Int J Mol Sci，2021，22（8）：4070.
24. 24.
    JIANG Y，XIE F，LV X，et al.Mefunidone ameliorates diabetic kidney disease in STZ and db/db mice［J］.FASEB J，2021，35（1）：e21198.
25. 25.
    JAHAN H，SIDDIQUI N N，IQBAL S，et al. Indole-linked 1，2，3-triazole derivatives efficiently modulate COX-2 protein and PGE₂ levels in human THP-1 monocytes by suppressing AGE-ROS-NF-κB nexus［J］.Life Sci，2022，291：120282.
26. 26.
    WANG X，YAO B，WANG Y，et al.Macrophage cyclooxygenase-2 protects against development of diabetic nephropathy［J］.Diabetes，2017，66（2）：494-504.
27. 27.
    FENG X，WANG S，SUN Z，et al.Ferroptosis enhanced diabetic renal tubular injury via HIF-1α/HO-1 pathway in db/db mice［J］.Front Endocrinol（Lausanne），2021，12：626390.
28. 28.
    DEFRONZO R A，REEVES W B，AWAD A S. Pathophysiology of diabetic kidney disease：Impact of SGLT2 inhibitors［J］.Nat Rev Nephrol，2021，17（5）：319-334.
29. 29.
    LÖWEN J，GRÖNE E，GRÖNE H J，et al.Herniation of the tuft with outgrowth of vessels through the glomerular entrance in diabetic nephropathy damages the juxtaglomerular apparatus［J］.Am J Physiol Renal Physiol，2019，317（2）：F399-F410.
30. 30.
    CHEN M，ZHONG K，TAN J，et al.Baicalein is a novel TLR4-targeting therapeutics agent that inhibits TLR4/HIF-1α/VEGF signaling pathway in colorectal cancer［J］.Clin Transl Med，2021，11（11）：e564.
31. 31.
    SUN W X，GAO Y Y，CAO Y，et al.Catalpol prevents glomerular angiogenesis induced by advanced glycation end products via inhibiting galectin-3［J］.Curr Med Sci，2023，43（4）：668-678.
32. 32.
    XU Y，KONG X，LI J，et al.Mild hypoxia enhances the expression of HIF and VEGF and triggers the response to injury in rat kidneys［J］.Front Physiol，2021，12：690496.
33. 33.
    IKEDA M，IDE T，TADOKORO T，et al.Excessive hypoxia-inducible factor-1α expression induces cardiac rupture via p53-dependent apoptosis after myocardial infarction［J］.J Am Heart Assoc，2021，10（17）：e020895.
34. 34.
    YFANTIS A，MYLONIS I，SIMOS G.Direct interaction between mortalin and HIF-1α at the mitochondria inhibits apoptosis by blocking recruitment of Bax［J］.FEBS J，2023，290（15）：3764-3780.
35. 35.
    FU M，PENG D，LAN T，et al. Multifunctional regulatory protein connective tissue growth factor（CTGF）：A potential therapeutic target for diverse diseases［J］.Acta Pharm Sin B，2022，12（4）：1740-1760.
36. 36.
    QIAN L，REN S，XU Z，et al. Qianyang Yuyin granule improves renal injury of hypertension by regulating metabolic reprogramming mediated by HIF-1α/PKM2 positive feedback loop［J］.Front Pharmacol，2021，12：667433.
37. 37.
    ARELLANO-BUENDÍA A S，CASTAÑEDA-LARA L G，LOREDO-MENDOZA M L，et al.Effects of allicin on pathophysiological mechanisms during the progression of nephropathy associated to diabetes［J］.Antioxidants（Basel），2020，9（11）：1134.
38. 38.
    LIU L，ZHANG P，BAI M，et al. p53 upregulated by HIF-1α promotes hypoxia-induced G₂/M arrest and renal fibrosis in vitro and in vivo［J］.J Mol Cell Biol，2019，11（5）：371-382.
39. 39.
    ZHAO H，HAN Y，JIANG N，et al.Effects of HIF-1α on renal fibrosis in cisplatin-induced chronic kidney disease［J］.Clin Sci（Lond），2021，135（10）：1273-1288.
40. 40.
    SUN S，NING X，ZHANG Y，et al.Hypoxia-inducible factor-1alpha induces Twist expression in tubular epithelial cells subjected to hypoxia， leading to epithelial-to-mesenchymal transition［J］.Kidney Int，2009，75（12）：1278-1287.
41. 41.
    HE Y P，JIA D K，CHEN W Y，et al.Research progress on traditional Chinese medicine intervention in diabetic nephropathy based on mitophagy［J］.Inf Tradit Chin Med，2024，41（11）：72-78.
42. 42.
    CUI K，LIU J，HUANG L，et al.Andrographolide attenuates choroidal neovascularization by inhibiting the HIF-1α/VEGF signaling pathway［J］.Biochem Biophys Res Commun，2020，530（1）：60-66.
43. 43.
    LV B，ZHENG K，SUN Y，et al.Network pharmacology experiments show that emodin can exert a protective effect on MCAO rats by regulating Hif-1α/VEGF-A signaling［J］.ACS Omega，2022，7（26）：22577-22593.
44. 44.
    XU W L，LIU S，LI N，et al.Quercetin antagonizes glucose fluctuation induced renal injury by inhibiting aerobic glycolysis via HIF-1α/miR-210/ISCU/FeS pathway［J］.Front Med（Lausanne），2021，8：656086.
45. 45.
    CHEN S L，KANG Z F，CHU W L，et al.Mechanism study of curcumin on inhibiting experimental choroidal neovascularization in vitro by Akt/HIF-1α/VEGF pathway ［J］.Int Eye Sci， 2022，22（4）：541-548.
46. 46.
    HOU J.Effect of Huangkui capsule and tretinoin polyglucoside combined with valsartan in the treatment of patients with stage Ⅳ diabetic nephropathy［J］.Henan Med Res，2020，29（22）：4145-4147.
47. 47.
    DONG X G，AN Z M，GUO Y，et al. Effect of triptolide on expression of oxidative carbonyl protein in renal cortex of rats with diabetic nephropathy［J］.J Huazhong Univ Sci Technol Med Sci，2017，37（1）：25-29.
48. 48.
    YU X H，HE Y L，YANG Y F，et al.Tripterygium Glycosides tablets affect the levels of heat shock protein 90 and PGC-1α in rats with diabetic nephropathy through PI3K/Akt pathway［J］.China J Mod Med，2021，31（22）：10-16.
49. 49.
    LI M X，QIAO H X，WANG X L，et al.Effects of tripterygium glycosides on high glucose induced apoptosis of human renal tubular epithelial cells and CXCL10/CXCR3 axis ［J］.Tianjin Med J，2023，51（2）：139-143.
50. 50.
    JIANG S，FAN F，YANG L，et al.Salidroside attenuates high altitude hypobaric hypoxia-induced brain injury in mice via inhibiting NF-κB/NLRP3 pathway［J］.Eur J Pharmacol，2022，925：175015.
51. 51.
    PEI D，TIAN S，BAO Y，et al.Protective effect of salidroside on streptozotocin-induced diabetic nephropathy by inhibiting oxidative stress and inflammation in rats via the Akt/GSK-3β signalling pathway［J］.Pharm Biol，2022，60（1）：1732-1738.
52. 52.
    XIE R Y，FANG X L，HAMZE I，et al.Salidroside attenuates high glucose-induced rat renal glomerular endothelial cell injury via up-regulating HIF-1α expression［J］.Chin J Pathophysiol，2019，35（2）：237-242.
53. 53.
    WANG S，ZHAO X，YANG S，et al. Salidroside alleviates high glucose-induced oxidative stress and extracellular matrix accumulation in rat glomerular mesangial cells by the TXNIP-NLRP3 inflammasome pathway［J］.Chem Biol Interact，2017，278：48-53.
54. 54.
    SHAN J P，GUAN J C，DONG Z C，et al.Cordyceps sinensis ameliorates cisplatin-induced nephrotoxicity in mice through inhibition of oxidative stress，inflammation，and apoptosis［J］.Chin J Integr Tradit West Nephrol，2019，20（6）：474-477，565.
55. 55.
    ZHANG L Y，JIN J，JIN J Z，et al.Cordyceps sinensis protects against tacrolimus-induced pancreatic and pe-nal injury［J］.Chin J Gerontol，2019，39（2）：361-367.
56. 56.
    YUAN M X，TANG R，ZHOU Q L，et al.Effect of Cordyceps sinensis on expressions of HIF-1α and VEGF in the kidney of rats with diabetic nephropathy［J］.J Central South Univ： Med Sci，2013，38（5）：448-457.
57. 57.
    KU C W，HO T J，HUANG C Y，et al.Cordycepin attenuates palmitic acid-Induced inflammation and apoptosis of vascular endothelial cells through mediating PI3K/Akt/eNOS signaling pathway［J］.Am J Chin Med，2021，49（7）：1703-1722.
58. 58.
    SHAO Y，LV C，WU C，et al.Mir-217 promotes inflammation and fibrosis in high glucose cultured rat glomerular mesangial cells via Sirt1/HIF-1α signaling pathway［J］.Diabetes Metab Res Rev，2016，32（6）：534-543.
59. 59.
    DU L，WANG L，WANG B，et al.A novel compound AB38b attenuates oxidative stress and ECM protein accumulation in kidneys of diabetic mice through modulation of Keap1/Nrf2 signaling［J］.Acta Pharmacol Sin，2020，41（3）：358-372.
60. 60.
    SONG W，LIU G Y，TIAN H，et al.Effects of piceatannol on renal fibrosis and HO-1 and HIF-1 a expressions in diabetic nephropathy rats［J］.Acta Nutr Sin，2021，43（1）：86-91.
61. 61.
    CHEN W，TIAN L，LI Y，et al.Effects of momordica total saponins to HIF-1α and VEGF expression in kidney tissue of type 2 diabetic nephropathy rats［J］.Global Tradit Chin Med，2016，9（6）：659-663.
62. 62.
    CHEN J，OU Z，GAO T，et al.Ginkgolide B alleviates oxidative stress and ferroptosis by inhibiting GPX4 ubiquitination to improve diabetic nephropathy［J］.Biomed Pharmacother，2022，156：113953.
63. 63.
    WILLSON J A，ARIENTI S，SADIKU P，et al.Neutrophil HIF-1α stabilization is augmented by mitochondrial ROS produced via the glycerol 3-phosphate shuttle［J］.Blood，2022，139（2）：281-286.
64. 64.
    WANG Y，CAO Z，WEI Q，et al. VH298-loaded extracellular vesicles released from gelatin methacryloyl hydrogel facilitate diabetic wound healing by HIF-1α-mediated enhancement of angiogenesis［J］.Acta Biomater，2022，147：342-355.
65. 65.
    FU Z J，WANG Z Y，XU L，et al. HIF-1α-BNIP3-mediated mitophagy in tubular cells protects against renal ischemia/reperfusion injury［J］.Redox Biol，2020，36：101671.
66. 66.
    XU B，ZHENG J，TIAN X，et al. Protective mechanism of traditional Chinese medicine Guizhi Fuling pills against carbon tetrachloride-induced kidney damage is through inhibiting oxidative stress， inflammation and regulating the intestinal flora［J］.Phytomedicine，2022，101：154129.
67. 67.
    YANG Y Q，TAN H B，ZHANG X Y，et al.The Chinese medicine Fufang Zhenzhu Tiaozhi capsule protects against renal injury and inflammation in mice with diabetic kidney disease［J］.J Ethnopharmacol，2022，292：115165.